Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation
Objective
The purpose of this study is to compare the efficacy and safety between pulmonary vein isolation (PVI) alone versus PVI with left atrial (LA) posterior wall isolation (PWI) using pulsed-field ablation (PFA) in the treatment of patients with paroxysmal atrial fibrillation (PAF).
Study Arms
- Active Comparator: Pulmonary Vein Isolation (PVI) only
- Active Comparator: Pulmonary Vein Isolation and Posterior Wall Isolation ( PVI+PWI)
Eligibility
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Age 21-90 years.
- Symptomatic PAF whether failed AAD or not.
- At least one symptomatic episode of PAF lasting <7 days, documented on electrocardiogram (ECG), Holter, ZioPatch, ILR, or smartwatch recording in the year prior to enrollment.
- Patients undergoing first time ablation for AF.
- Subject has any commercially available implantable loop recorder (ILR) or agrees to have one implanted prior or during the ablation procedure.
NCT ID
NCT06364215
